Calcium overload-induced apoptosis in cancer cells: ER-mitochondria crosstalk and therapeutic implications.
- 2026-12
- Pharmaceutical science advances 4
- Yucui Ding
- Xinyu Liu
- Jianyue Xue
- Jianlong Fu
- Sha Liu
- Xiaopeng Xu
- Xiang Jiao
- Zhenyong Wu
- Ganqiang Yang
- Hongbo Wang
- Peng Zhang
- PubMed: 42388522
- DOI: 10.1016/j.pscia.2026.100129
Study Design
- Type
- Review
Calcium overload exhibits significant anti-tumor potential by inducing abnormal intracellular Ca2+ accumulation, which disrupts mitochondrial and endoplasmic reticulum (ER) functions, thereby triggering apoptosis. However, its clinical application is currently hindered by challenges such as poor tumor-targeting capabilities, insufficient tumor accumulation, and incomplete mechanistic understanding. This review systematically analyzes the structural and functional coupling between the ER and mitochondria to elucidate the mechanisms of calcium overload-mediated cell death. We highlight how Ca2+ acts as a critical trigger to amplify mitochondria-associated ER stress, fostering a self-amplifying loop of crosstalk that initiates tumor cell death pathways. Furthermore, we summarize recent advances in targeted Ca2+ delivery using calcium-based nanocarriers combined with emerging modalities like sonodynamic therapy (SDT) and photothermal therapy (PTT), highlighting their synergistic antitumor potential. Compared with previous reviews, this work focuses on recent calcium-based nanosystems, sequential ER-mitochondria damage during Ca2+ overload, the MAM-associated IP3R-GRP75-VDAC1-MCU axis, and future strategies for tumor-targeted, TME-responsive, and multimodal synergistic therapy. By summarizing current research, this review aims to provide a prospective outlook for the novel anti-cancer therapies that target the disruption of intracellular Ca2+ homeostasis.